(Q20746326)

30 July 2017

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial (English)

1 reference

30 July 2017

0 references

0 references

1 reference

1

M B Keller

M B

Keller

1 reference

21 July 2022

11

G J

Emslie

G J Emslie

1 reference

30 July 2017

N D Ryan

2

N D

Ryan

1 reference

30 July 2017

M Strober

3

M

Strober

1 reference

30 July 2017

R G Klein

4

R G

Klein

1 reference

30 July 2017

S P Kutcher

5

S P

Kutcher

1 reference

30 July 2017

B Birmaher

6

B

Birmaher

1 reference

30 July 2017

O R Hagino

7

O R

Hagino

1 reference

30 July 2017

H Koplewicz

8

H

Koplewicz

1 reference

30 July 2017

G A Carlson

9

G A

Carlson

1 reference

30 July 2017

G N Clarke

10

G N

Clarke

1 reference

30 July 2017

D Feinberg

12

D

Feinberg

1 reference

30 July 2017

B Geller

13

B

Geller

1 reference

30 July 2017

V Kusumakar

14

V

Kusumakar

1 reference

30 July 2017

G Papatheodorou

15

G

Papatheodorou

1 reference

30 July 2017

W H Sack

16

W H

Sack

1 reference

30 July 2017

M Sweeney

17

M

Sweeney

1 reference

30 July 2017

K D Wagner

18

K D

Wagner

1 reference

30 July 2017

E B Weller

19

E B

Weller

1 reference

30 July 2017

N C Winters

20

N C

Winters

1 reference

30 July 2017

R Oakes

21

R

Oakes

1 reference

30 July 2017

J P McCafferty

22

J P

McCafferty

1 reference

30 July 2017

1 July 2001

1 reference

Journal of the American Academy of Child and Adolescent Psychiatry

30 July 2017

1 reference

30 July 2017

40

1 reference

30 July 2017

762-772

1 reference

30 July 2017

7

1 reference

A diagnostic interview: the schedule for affective disorders and schizophrenia

30 July 2017

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Depressed Adolescents Grown Up

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Adolescent depression: controlled desipramine treatment and atypical features

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Amitriptyline in children with major depressive disorder: a double-blind crossover pilot study

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Clinical effects of amitriptyline in adolescent depression. A pilot study

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Child and adolescent mood disorders--experience with serotonin-based therapies

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study1Presented at the American Academy of Child and Adolescent Psychiatry 42nd Annual Meeting, New Orleans, LA, 19 October 19

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Placebo as a treatment for depression.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Psychopharmacology of child and adolescent major depression: present status and future directions

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

An open study of the effects of sertraline on adolescent major depression

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Unipolar depression in adolescents: clinical outcome in adulthood.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Dysthymic disorder in clinically referred preschool children

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Analog classroom assessment of Adderall in children with ADHD.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Multicenter open-label sertraline study in adolescent outpatients with major depression.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls.

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

1 reference

https://api.crossref.org/works/10.1097%2F00004583-200107000-00010

7 January 2021

10.1097/00004583-200107000-00010

Identifiers

DOI

1 reference

30 July 2017

0 references

1 reference